z-logo
open-access-imgOpen Access
miR-222 expression is correlated with the ATA risk stratifications in papillary thyroid carcinomas∗
Author(s) -
Dong Xiang,
Bin Tian,
Tianyao Yang,
Zhiyu Li
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000016050
Subject(s) - medicine , thyroid carcinoma , stage (stratigraphy) , goiter , oncology , metastasis , lymph node , thyroid cancer , microrna , thyroid , pathology , cancer , gastroenterology , gene , biology , paleontology , biochemistry
Abstract Background: miR-222 is one of the most consistently overexpressed miRNAs in papillary thyroid carcinoma (PTC). Previous studies demonstrated that miR-222 overexpression conferred high-risk features in PTC patients, suggesting its value in risk-stratification. However, studies in term of miR-222's utility on stratifying PTCs are lacking. Methods: One hundred patients including 10 with multinodular goiter and 90 with PTC were enrolled. Formalin-fixed paraffin-embedded samples were exploited for miR-222 quantitative reverse transcriptase- polymerase chain reaction (RT-PCR) analysis. Correlations between miR-222 expression and different clinicopathological features, Tumor-node-metastasis (TNM) staging and ATA risk level were analyzed. Results: miR-222 expression of the PTC group was significantly higher than that of the goiter group ( P  < .001). Furthermore, miR-222 expression was significantly higher in PTCs with advanced features like larger tumor, capsular invasion, vascular invasion and lymph nodes metastasis. The majority of patients (61%) were in stage I group (similar to ATA low-risk) by TNM staging system. As to the ATA system, the majority (73%) were in intermediate-risk group (similar to TNM stage II and III roughly). Contrary to previous report, here we found that miR-222 expression was correlated with the ATA risk level ( P  < .001), but not with the TNM staging ( P  = .122). Conclusion: In the present study, we demonstrated that miR-222 overexpression was correlated with advanced features like capsular invasion, vascular invasion, larger tumor size and lymph node metastasis in PTCs. Most importantly, miR-222 expression was correlated with ATA risk levels, suggesting its potential value in PTC risk-stratification.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here